Total Results: 12373
More than 55 million women have access to birth control without copayments because of the contraceptive coverage mandate in the Affordable Care Act.
“If it gets signed by this governor, it’s going to send shock waves throughout the country,” one legislator says. Pharma has spent $16.8 million lobbying against this bill and other drug laws in California.
“It looks more like a part of the developing world than it looks like the United States of America,” Robin Koval, president of the Truth Initiative which released the report, says of the 12 states. In other public health news: blood pressure, a mysterious illness, domestic violence and rare genetic diseases.
Las Vegas only has one of these “gold standard” centers, but it’s not the only big city to have so few. Experts say that in situations such as Sunday’s mass shooting what matters most is not the number of high-level centers, but the degree of coordination across a region’s medical network.
Politico reporters describe what went into tracking former HHS Secretary Tom Price’s use of chartered jets. In other news, House Democrats want details on White House adviser Kellyanne Conway’s trips.
Teva had lobbied the Food and Drug Administration to reject Mylan’s generic version of its Copaxone multiple sclerosis medication. In other drug industry news: an experimental drug is found to work on a mutant gene; advocates await Calif. Gov. Jerry Brown’s decision on a drug pricing bill; and Cleveland Clinic’s CEO wants supporters of a drug pricing ballot measure in Ohio to stop using his image.
But Republicans are not actually planning to impose any of those cuts which are limited to nonbinding promises. Meanwhile, angry Republican donors are sitting on their wallets until lawmakers actually accomplish something.
En la ciudad hay un solo centro de trauma, especializado en tratar a pacientes con lesiones severas producto de disparos, caídas o accidentes automovilísticos. Qué pasa a nivel nacional
Hospitals view adding trauma care as a potential profit tool, but experts say having more centers does not necessarily improve the system’s ability to respond to a mass casualty event.
Read recent commentaries about drug-cost issues.
News outlets report on stories related to pharmaceutical pricing.
An investigation by Reveal from The Center for Investigative Reporting found that these facilities, which are meant to be an alternative to jail for those addicted to substances, can be nothing more than “slave camps.” In other public health news: genetic testing, the immune system, Pompe disease, pets and cancer, vaccinations, dementia and more.
“You’re standing in a pool of blood trying to care for your patient, slipping and sliding,” said trauma nurse Renae Huening. Meanwhile, officials are seeking certified trauma counselors to help serve the mental health needs of those who were affected by the shooting.
The House Energy and Commerce panel added the delay of disproportionate-share hospital funding cuts to the CHIP reauthorization bill. Hospitals in New Jersey, Texas and Massachusetts also make headlines today.
Scott Gottlieb has won over many criticis by seeking to widen access to generic drugs, asserting that the agency should play a role in addressing the nation’s opioid epidemic, and announcing plans to tighten regulations on tobacco products. In other news, House Speaker Paul Ryan (R-Wis.) reportedly asked the White House to reconsider Tom Price’s departure before the resignation of the secretary of Health and Human Services was announced.
Despite the push by Sen. Bill Cassidy (R-La.) to revive the stalled Republican Graham-Cassidy legislation, Senate leaders and committees have not given any hints that they expect the measure to come up again soon.
A selection of opinions on health care from around the country.
Media outlets report on news from Maryland, Florida, Texas and Georgia.
Shire says it offered discounts to Medicare Part D plans, but the program refused due to Allergan’s “bundled discounts, exclusive dealing” and other tactics.
The head of the Food and Drug Administration says in a blog post that his agency will provide guidance to drugmakers on how to win approvals for these medications that are especially hard to make. In congressional testimony, he also says the agency supports “right-to-try” legislation that allows people with serious illnesses access to experimental drugs, but he would like the measure to apply only to people with terminal diseases.